Transplant Diagnostics Market exhibiting CAGR of 7.2% by 2032, owing to increasing number of transplantation procedures | insightSLICE
The market for Transplant Diagnostics was valued at $3.95 billion in 2021 and is anticipated to grow at a CAGR of 7.2% through 2032.
One of the most popular treatments used when an organ fails is organ transplantation. In order to make the human body work normally, the injured organ is replaced with one that is fully functional. Failure of essential organs such as the liver, pancreas, lungs, kidney, and heart require organ transplantation process.
The antigen known as human leukocyte antigen (HLA) is found on the cell surface and controls immune reactions when foreign tissue is present. This can occasionally result in the rejection of transplanted foreign tissue.
Access the sample report: https://www.insightslice.com/request-sample/544
This is a crucial issue that arises due to the human major histocompatibility complex reaction to the graft. To ascertain compatibility between the donor and receiver for organ and bone marrow transplantation, HLA diagnostic testing is carried out.
This information can then be utilized to establish whether the recipient’s body would tolerate a transplant or not.
When the donor and recipient’s HLA markers closely match, the graft is effective and this reduces the likelihood of rejection of the transplanted organ or tissue. Both molecular and non-molecular assays are utilized in diagnostic technology.
The conventional diagnostic approach, known as a non-molecular assay, provides quick results at a reasonable price.
This aids the user in practicing antibody-based histocompatibility tests, which assemble cells into cultures and provide lower precision typing than molecular assays.The Polymerase Chain Reaction (PCR) method and sequencing-based test are both used in the molecular assay.
The key players of the Global Transplant Diagnostics Market are:
Key players present in the global Transplant diagnostics market are F. Hoffmann-LA Roche, Ltd., Abbott Laboratories, Inc. Bio-Rad Laboratories, Inc., Linkage Biosciences Olerup SSP AB, Qiagen N.V., Sigma-Aldrich Thermo Fisher Scientific Inc., Illumina Inc., Immucor Inc.
Competitive techniques and dominant companies in the Global Transplant diagnostics market:
To improve their market position, businesses are pursuing organic growth techniques. For instance, Siemens stated in April 2016 that they had partnered with Thermo Fisher.
Thermo Fisher was permitted by Siemens to use its real-time PCR technique with Siemens’s technology as part of this deal. Providing a sensitive and quick detection limit was meant to improve the overall quality and duration of the diagnostic.
Read more about the report inclusions: https://www.insightslice.com/transplant-diagnostics-market
Benefits of the Transplant Diagnostics process during organ or tissue transplant:
Numerous advantages and features provided by transplant diagnostics aid medical experts in improving the viability of the transplantation process for positive outcomes.
Transplant diagnostics aid in the discovery of cell molecules implicated in the immunological rejection of mismatched grafts as well as the detection of foreign HLA Class 2 antigens.
These characteristics assist medical professionals, such as doctors and nurses, in streamlining the transplantation procedures needed for individuals to sustain an efficient daily workflow. These elements are anticipated to assist market expansion in the upcoming years.
Rising Patient Population with Targeted Diseases may drive market growth:
Transplant Diagnostic testing equipment, reagents, and consumables are in high demand worldwide due to their low cost and quick results. The adoption of stem cell therapy, an increase in patients with chronic illnesses that cause organ failure, and other variables are what is causing the need to expand so quickly.
The need for pre-procedure diagnostics has resulted from this. Diagnostic testing has two different types of applications: those in healthcare and those in research.
The development of value-added features that make diagnostic testing increasingly productive and efficient, including real-time PCR technology, PCR-enzyme-linked immunosorbent assay, and imaging components, is a top priority for international practitioners.
Global Transplant Diagnostics Market Key Segments:
By Technology:
- Molecular Assay Technologies
- Sequencing-based Molecular Assays
- PCR-Based Molecular Assays
- Non-molecular Assay Technologies
By Product & Service:
- Software & Services
- Instruments
- Reagents & Consumables
By Transplant Type:
- Bone marrow Transplantation
- Solid Organ Transplantation
- Soft Tissue Transplantation
- Stem Cell Transplantation
By Application:
- Diagnostic Applications
- Pre-transplantation Diagnostics
- Post-transplantation Diagnostics
- Research Applications
By End-User:
- Research Laboratories & Academic Institutes
- Hospitals & Transplant Centers
- Independent Reference Laboratories
By Geography
- North America
- United States
- Canada
- Rest of North America
- Europe
- Germany
- United Kingdom
- Belgium
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- India
- China
- Australia
- Rest of Asia Pacific
- Middle East & Africa
- UAE
- Saudi Arabia
- Rest of Middle East & Africa
- South America
- Brazil
- Rest of South America
Related reports:
Global Live Cell Encapsulation Market: https://www.insightslice.com/live-cell-encapsulation-market
Global Nuclear Imaging Equipment Market: https://www.insightslice.com/nuclear-imaging-equipment-market
The end-user segments that generate the most revenue are hospitals and transplant centers:
The main end-users of transplant diagnostics include hospitals, transplant centers, reference laboratories, research centers, academic institutions, and commercial service providers. Throughout the projected period, hospitals and transplant centers are anticipated to rule the global market.
Increased patient flow in hospitals and transplant facilities is a result of the high incidence of bone injuries, renal failures, and cases of cancer and genetic condition among the world’s population.
Presently the global market for transplant diagnostics is dominated by the North American region:
All across North America, there is an increasing demand for transplant diagnostics. Because of the lower average cost of gene sequencing, private-public funding for the advancement of HLA typing technology, expanding stem cell population, and solid organ-based transplantation in the region, North America is the global center for transplant diagnostics.
Due to actions by the European Commission for organ harvesting that improve the availability of donor organs, Europe is a region with similar potential for the transplant diagnostic market.
The significant market share represented by the solid organ transplantation sector of the worldwide market is the result of the various reimbursement and Medicare benefits provided to patients for the treatment of diseases.
During the projection period, it is anticipated that the Transplant Diagnostic Market would increase to its full potential in Asian nations like China, India, and Japan, as well as at a modest rate in South American nations like Argentina and Brazil.
Proceed to purchase: https://www.insightslice.com/buy-now/544
insightSLICE is a market intelligence and strategy consulting company. The company provides tailor-made and off the shelf market research studies. The prime focus of the company is on strategy consulting to provide end-to-end solutions. For more details, please contact our research and consulting team at info@insightslice.com.
Contact us:
Alex R
+1 707 736 6633
Editor Details
-
Company:
- insightSLICE
- Website:
